Holen Sie sich die Stockscreener-App
0.595
0.00%
0.00
Handel nachbörslich:
.59
-0.005
-0.84%
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
15.60%
9.8294
|
8.503 | - | 5.677 | 4.4863 |
| Depreciation and Amortization |
0.03%
0.00382
|
0.00382 | - | - | - |
| Operating Income/Loss |
15.60%
-9.8294
|
-8.503 | -7.7058 | -5.677 | -4.4863 |
| Nonoperating Income/Loss |
110.28%
-1.4861
|
14.46 | 5.2871 | 0.7816 | -7.3954 |
| Income/Loss From Continuing Operations Before Tax |
290.20%
-11.33
|
5.9589 | -2.4187 | -4.8954 | -11.88 |
| Income/Loss From Continuing Operations After Tax |
290.20%
-11.33
|
5.9589 | -2.4187 | -4.8954 | -11.88 |
|
Net Income/Loss
|
290.20%
-11.33
|
5.9589 | -2.4187 | -4.8954 | -11.88 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
7.88%
-0.0393
|
-0.0427 | - | - | - |
| Basic Average Shares |
0.00%
15.98
|
15.98 | 0.1016 | 15.52 | 15.52 |
| Diluted Average Shares |
4.16%
15.98
|
16.67 | 0.1016 | 15.52 | 15.52 |
| Basic Earnings Per Share |
286.84%
-0.71
|
0.38 | - | - | -0.77 |
| Diluted Earnings Per Share |
42.00%
-0.71
|
-0.50 | -0.15 | -0.32 | -0.77 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):